跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,805 条关于
“MyRisk Hereditary Cancer Test”
全部
18,805
临床试验
7
药物
0
机构
1,235
资讯
17,563
去年
Myriad Genetics' RiskScore Study Recognized as a Top Advance in Genomic Medicine
10个月前
Clairity, Myriad Genetics, and MagView Launch First Integrated AI-Genetic Risk Platform for Breast Cancer Screening
去年
Myriad Genetics Partners with Gabbi to Expand Hereditary Cancer Risk Testing Access
9个月前
Zydus Partners with Myriad Genetics to Bring Advanced Cancer Risk Assessment Tests to India
去年
Myriad Genetics' RiskScore Study Shows Improved Breast Cancer Screening Personalization
去年
Myriad Genetics Reports Strong Q2 2025 Results, Pivots Strategy to Focus on Cancer Care Continuum
去年
Ambry Genetics' CARE Program Achieves 99.5% Accuracy in Hereditary Cancer Risk Assessment
去年
Lenvatinib-Tislelizumab Combo Shows Promising 93% Response Rate in Rare Hereditary Kidney Cancer
去年
Maastricht UMC+ Develops Promising Drug for Hereditary Fructose Intolerance Treatment
去年
CHOP Researchers Propose ALK Inhibitors as New Standard for Hereditary Neuroblastoma
第 1 页，共 1757 页
上一页
下一页
